Reuters logo
BRIEF-Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen clinical trial
November 1, 2017 / 11:37 AM / in 20 days

BRIEF-Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen clinical trial

Nov 1 (Reuters) - Prometic Life Sciences Inc:

* Prometic receives clearance from the Swedish Medical Products Agency to initiate plasminogen clinical trial in chronic tympanic membrane perforation

* Prometic Life Sciences Inc - ‍up to 33 adult patients are expected to be enrolled in clinical trial​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below